Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Infections Disease Information》 1998-01
Add to Favorite Get Latest Update

Preliminary study on the inhibition of HBV PreS2 Gene expression by retroviral mediated ribozyme transfer

Xu Dongping,Han Fenglian,Shi Hong,et al.Biological Engineering Laboratory,Institute of Infectious Diseases,Beijing,100039  
In this paper, a multi-target hammerhead ri- bozyme gene was synthesized directed against 110, 122 and 132 sites of nucleotide of HBV preS2 gene. The target gene fragment was cut from HBV-genome-con- taining plasmid pCP10. Both of the ribozyme and tar- get gene fragments were cloned into pGEM3Zf(-) plasmid and sequenced by dideoxy chain termination method. The transcription of both gene fragments was performed in vitro utilizing T7 RNA promoter in pGEM3Zf(-) plasmid. The cleavage activity of ri- bozyme to substrate was confirmed in vitro. For fur- there valuating intracellular function of ribozyme, two ribozyme-retroviral recombinant plasmids with differ- ent promoter type pDOR-ripc and tRNA-ripc were constructed. Pseudo-virus was collected through rou- tine packaging procedure and transduced into 2. 2. 15 cells. RIA data showed a stable inhibition of pHSA-R antigen expression to the lowest extent of 41. 01%± 4. 16 and the highest extent of 51. 45%±4. 57 within 4 weeks after transduction. No influence, however, on HBsAg and HBeAg expression was demonstrated after ribozyme gene transfer.
【CateGory Index】: R346
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved